Top compounds associated with response to CLMN


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.07
mRNA BRD-K27224038 CTRPv2 pan-cancer AAC 0.15 0.08
mRNA Erlotinib gCSI pan-cancer AAC 0.11 0.08
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.08
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC -0.056 0.08
mRNA BMS-345541 CTRPv2 pan-cancer AAC 0.068 0.08
mRNA XL-184 GDSC1000 pan-cancer AAC -0.063 0.08
mRNA BX-912 GDSC1000 pan-cancer AAC -0.056 0.08
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.08
mRNA Irinotecan gCSI pan-cancer AAC -0.099 0.08
Download CSV